Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance.
García-Cano J, Ambroise G, Pascual-Serra R, Carrión MC, Serrano-Oviedo L, Ortega-Muelas M, Cimas FJ, Sabater S, Ruiz-Hidalgo MJ, Sanchez Perez I, Mas A, Jalón FA, Vazquez A, Sánchez-Prieto R. García-Cano J, et al. Among authors: sanchez prieto r, sanchez perez i. Oncotarget. 2015 Jun 20;6(17):15551-65. doi: 10.18632/oncotarget.3902. Oncotarget. 2015. PMID: 26036632 Free PMC article.
Control of oncogenesis and cancer therapy resistance.
Perona R, Sánchez-Pérez I. Perona R, et al. Among authors: sanchez perez i. Br J Cancer. 2004 Feb 9;90(3):573-7. doi: 10.1038/sj.bjc.6601552. Br J Cancer. 2004. PMID: 14760366 Free PMC article. Review.
MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.
Cortes-Sempere M, Chattopadhyay S, Rovira A, Rodriguez-Fanjul V, Belda-Iniesta C, Tapia M, Cejas P, Machado-Pinilla R, Manguan-García C, Sánchez-Pérez I, Nistal M, Moratilla C, de Castro-Carpeño J, Gonzalez-Barón M, Albanell J, Perona R. Cortes-Sempere M, et al. Among authors: sanchez perez i. Cancer Lett. 2009 Dec 28;286(2):206-16. doi: 10.1016/j.canlet.2009.05.029. Epub 2009 Jun 23. Cancer Lett. 2009. PMID: 19553005
E1a promotes c-Myc-dependent replicative stress: implications in glioblastoma radiosensitization.
Valero ML, Cimas FJ, Arias L, Melgar-Rojas P, García E, Callejas-Valera JL, García-Cano J, Serrano-Oviedo L, de la Cruz-Morcillo MÁ, Sánchez-Pérez I, Sánchez-Prieto R. Valero ML, et al. Among authors: sanchez prieto r, sanchez perez i. Cell Cycle. 2014;13(1):52-61. doi: 10.4161/cc.26754. Epub 2013 Oct 11. Cell Cycle. 2014. PMID: 24196438 Free PMC article.
CHK1 expression in Gastric Cancer is modulated by p53 and RB1/E2F1: implications in chemo/radiotherapy response.
Bargiela-Iparraguirre J, Prado-Marchal L, Fernandez-Fuente M, Gutierrez-González A, Moreno-Rubio J, Muñoz-Fernandez M, Sereno M, Sanchez-Prieto R, Perona R, Sanchez-Perez I. Bargiela-Iparraguirre J, et al. Among authors: sanchez prieto r, sanchez perez i. Sci Rep. 2016 Feb 12;6:21519. doi: 10.1038/srep21519. Sci Rep. 2016. PMID: 26867682 Free PMC article.
P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy.
Fernández-Aroca DM, Roche O, Sabater S, Pascual-Serra R, Ortega-Muelas M, Sánchez Pérez I, Belandia B, Ruiz-Hidalgo MJ, Sánchez-Prieto R. Fernández-Aroca DM, et al. Among authors: sanchez prieto r, sanchez perez i. Cancer Lett. 2019 Jun 1;451:23-33. doi: 10.1016/j.canlet.2019.02.049. Epub 2019 Mar 11. Cancer Lett. 2019. PMID: 30872077 Free article.
ERK5 signalling pathway is a novel target of sorafenib: Implication in EGF biology.
Ortega-Muelas M, Roche O, Fernández-Aroca DM, Encinar JA, Albandea-Rodríguez D, Arconada-Luque E, Pascual-Serra R, Muñoz I, Sánchez-Pérez I, Belandia B, Ruiz-Hidalgo MJ, Sánchez-Prieto R. Ortega-Muelas M, et al. Among authors: sanchez prieto r, sanchez perez i. J Cell Mol Med. 2021 Nov;25(22):10591-10603. doi: 10.1111/jcmm.16990. Epub 2021 Oct 16. J Cell Mol Med. 2021. PMID: 34655447 Free PMC article.
121 results